"Good luck, social distance": rapid decarceration and community care for serious mental illness and substance use disorder during the COVID-19 pandemic.
James JE, Dauria EF, Desai R, Bell A, Izenberg JM.
Health Justice. 2023 Sep 18;11(1):39. doi: 10.1186/s40352-023-00238-5. PMID: 37721650; PMCID: PMC10506186.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506186/
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences.
McDonald R, Bech AB, Clausen T.
BMC Health Serv Res. 2023 Sep 7;23(1):965. doi: 10.1186/s12913-023-09959-7. PMID: 37679751; PMCID: PMC10485985.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485985/
Trends in Opioid Medication Adherence During the COVID-19 Pandemic: Retrospective Cohort Study.
Marashi A, Warren D, Call G, Dras M.
JMIR Public Health Surveill. 2023 Sep 1;9:e42495. doi: 10.2196/42495. PMID: 37656492; PMCID: PMC10504620.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504620/
Early COVID-Related pandemic impacts and subsequent opioid outcomes among persons receiving medication for opioid use disorder: a secondary data analysis of a Type-3 hybrid trial.
Janssen T, Garner BR, Yermash J, Yap KR, Becker SJ.
Addict Sci Clin Pract. 2023 Sep 13;18(1):54. doi: 10.1186/s13722-023-00409-7. PMID: 37705105; PMCID: PMC10500804.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500804/
Implementation and Outcome Evaluation of LA DOOR: A Proposition 47-Funded Program in Los Angeles: Cohort 2 Final Evaluation Report.
Labriola MM, Sobol D, Sims H, Holliday SB.
Rand Health Q. 2023 Sep 15;10(4):4. PMID: 37720070; PMCID: PMC10501826.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501826/
Doing community-based research during dual public health emergencies (COVID and overdose).
Beck McGreevy P, Wood S, Thomson E, Burmeister C, Spence H, Pelletier J, Giesinger W, McDougall J, McLeod R, Hutchison A, Lock K, Norton A, Barker B, Urbanoski K, Slaunwhite A, Nosyk B, Pauly B.
Harm Reduct J. 2023 Sep 15;20(1):135. doi: 10.1186/s12954-023-00852-4. PMID: 37715202; PMCID: PMC10504762.
https://pubmed.ncbi.nlm.nih.gov/37715202/
COVID-19 and Chinese nurses' mental health
Zhang, Hong
The Lancet, Volume 402, Issue 10407, 1039 – 1040
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01418-6/fulltext
'It's a fragile open door'-enhancing COVID-19 vaccination rates in people receiving treatment for substance use disorder.
Murnion B, Carland JE, Jefferies M, Au M, Tracy M.
J Public Health (Oxf). 2023 Sep 14:fdad181. doi: 10.1093/pubmed/fdad181. Epub ahead of print. PMID: 37709530.
https://academic.oup.com/jpubhealth/advance-article/doi/10.1093/pubmed/fdad181/7273704
Changes in Opioid Agonist Treatment Practice in Germany during the COVID-19 Pandemic: What Have Physicians Done, and What Would They Like to Keep Doing?
Lehmann K, Kuhn S, Schulte B, Verthein U.
Eur Addict Res. 2023 Aug 9:1-10. doi: 10.1159/000531593. Epub ahead of print. PMID: 37557092.
Abstract
https://karger.com/ear/article-abstract/doi/10.1159/000531593/855543/Changes-in-Opioid-Agonist-Treatment-Practice-in
Opinion. In Wuhan, doctors knew the truth. They were told to keep quiet.
In the first weeks of 2020, a radiologist at Xinhua Hospital in Wuhan, China, saw looming signs of trouble. He was a native of Wuhan and had 29 years of radiology experience. His job was to take computed tomography (CT) scans, looking at patients’ lungs for signs of infection.
And infections were everywhere. “I have never seen a virus that spreads so quickly,” he told a reporter for the investigative magazine Caixin. “This growth rate is too fast, and it is too scary.”
“The CT machines in the hospital were overloaded every day,” he added. “The machines are exhausted and often crash.”
But this tableau of chaos was hidden from the Chinese people — and the world — in early 2020. Chinese authorities had acknowledged on Dec. 31, 2019, that there were 27 cases of “pneumonia of unknown origin,” and 44 confirmed cases on Jan. 3, 2020. The Wuhan health commission reported 59 cases on Jan. 5, then abruptly reduced the number to 41 on Jan. 11, and claimed there was no evidence of human-to-human transmission or any signs of doctors getting sick. (Washington Post, USA, 22.08.2023)
https://www.washingtonpost.com/opinions/2023/08/22/wuhan-doctors-pandemic-china-coverup/
Clinician Perspectives on Delivering Medication Treatment for Opioid Use Disorder during the COVID-19 Pandemic: A Qualitative Evaluation.
Lott AM, Danner AN, Malte CA, Williams EC, Gordon AJ, Halvorson MA, Saxon AJ, Hagedorn HJ, Sayre GG, Hawkins EJ.
J Addict Med. 2023 Jul-Aug 01;17(4):e262-e268. doi: 10.1097/ADM.0000000000001156. Epub 2023 Mar 2. PMID: 37579107; PMCID: PMC10417321.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417321/
What can we learn from COVID-19 to improve opioid treatment? Expert providers respond.
Harris LM, Marsh JC, Khachikian T, Serrett V, Kong Y, Guerrero EG.
J Subst Use Addict Treat. 2023 Aug 29;154:209157. doi: 10.1016/j.josat.2023.209157. Epub ahead of print. PMID: 37652210.
Abstract
https://www.sciencedirect.com/science/article/abs/pii/S2949875923002084
Co-Constructing a Community-Based Telemedicine Program for People With Opioid Use Disorder During the COVID-19 Pandemic: Lessons Learned and Implications for Future Service Delivery.
Høj SB, de Montigny C, Chougar S, Léandre R, Beauchemin-Nadeau MÈ, Boyer-Legault G, Goyette A, Lamont SK, Bruneau J.
JMIR Public Health Surveill. 2023 Jul 26;9:e39236. doi: 10.2196/39236. PMID: 37494097.
https://publichealth.jmir.org/2023/1/e39236
Trends in Opioid Use Disorder Outpatient Treatment and Telehealth Utilization Before and During the COVID-19 Pandemic.
Tormohlen KN, Eisenberg MD, Fingerhood MI, Yu J, McCourt AD, Stuart EA, Rutkow L, Quintero L, White SA, McGinty EE.
Psychiatr Serv. 2023 Jul 18:appips20230102. doi: 10.1176/appi.ps.20230102. Epub ahead of print. PMID: 37461819.
Abstract
https://pubmed.ncbi.nlm.nih.gov/37461819/
Opioid use and COVID-19: a secondary analysis of the impact of relaxation of methadone take-home dosing guidelines on use of illicit opioids.
Panwala V, Thorn E, Amiri S, Socias ME, Lutz R, Amram O.
Am J Drug Alcohol Abuse. 2023 Jul 11:1-9. doi: 10.1080/00952990.2023.2222336. Epub ahead of print. PMID: 37433122.
Abstract
https://www.tandfonline.com/doi/abs/10.1080/00952990.2023.2222336
Editorial: Opioids in the time of the COVID-19 pandemic: from cellular mechanisms to public health policy.
John S, Walwyn DR, DeFea K, Hales TG, Walwyn W.
Front Pharmacol. 2023 Jul 14;14:1251958. doi: 10.3389/fphar.2023.1251958. PMID: 37521481; PMCID: PMC10380911.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380911/
Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020 [Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020].
Frauger E, Fouilhé N, Lacroix C, Daveluy A, Le Boisselier R, Bertin C, Revol B, Carton L, Chevalier C, Eiden C, Gibaja V, Aquizerate A, Chaouachi L, Bouquet E, Roussin A, Mallaret M, Micallef J.
Therapie. 2023 Jun 15:S0040-5957(23)00084-7. French. doi: 10.1016/j.therap.2023.06.004. Epub ahead of print. PMID: 37391322; PMCID: PMC10266982.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266982/
Augmentation des surdoses et décès en lien avec la consommation de méthadone durant la crise sanitaire liée au COVID-19 en 2020 [Increase of overdose and deaths related to methadone during COVID-19 epidemic in 2020].
Frauger E, Fouilhé N, Lacroix C, Daveluy A, Le Boisselier R, Bertin C, Revol B, Carton L, Chevalier C, Eiden C, Gibaja V, Aquizerate A, Chaouachi L, Bouquet E, Roussin A, Mallaret M, Micallef J.
Therapie. 2023 Jun 15:S0040-5957(23)00084-7. French. doi: 10.1016/j.therap.2023.06.004. Epub ahead of print. PMID: 37391322; PMCID: PMC10266982.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266982/
Trends in Opioid Toxicity-Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021.
Gomes T, Ledlie S, Tadrous M, Mamdani M, Paterson JM, Juurlink DN.
JAMA Netw Open. 2023 Jul 3;6(7):e2322303. doi: 10.1001/jamanetworkopen.2023.22303. PMID: 37418260; PMCID: PMC10329206.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329206/
Trends in Opioid Toxicity-Related Deaths in the US Before and After the Start of the COVID-19 Pandemic, 2011-2021.
Gomes T, Ledlie S, Tadrous M, Mamdani M, Paterson JM, Juurlink DN.
JAMA Netw Open. 2023 Jul 3;6(7):e2322303. doi: 10.1001/jamanetworkopen.2023.22303. PMID: 37418260; PMCID: PMC10329206.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329206/
Substance use disorders and COVID-19: reflections on international research and practice changes during the "poly-crisis".
Carver H, Ciolompea T, Conway A, Kilian C, McDonald R, Meksi A, Wojnar M.
Front Public Health. 2023 Jul 17;11:1201967. doi: 10.3389/fpubh.2023.1201967. PMID: 37529435; PMCID: PMC10390069.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390069/
Substance use disorders and COVID-19: reflections on international research and practice changes during the "poly-crisis".
Carver H, Ciolompea T, Conway A, Kilian C, McDonald R, Meksi A, Wojnar M.
Front Public Health. 2023 Jul 17;11:1201967. doi: 10.3389/fpubh.2023.1201967. PMID: 37529435; PMCID: PMC10390069.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390069/
An interrupted time series analysis of trends in opioid-related emergency department visits from pre-COVID-19 pandemic to pandemic, from the Canadian Hospitals Injury Reporting and Prevention Program.
Yao X, McFaull SR, Champagne AS, Thompson W.
BMC Public Health. 2023 Aug 4;23(1):1483. doi: 10.1186/s12889-023-16414-z. PMID: 37537534; PMCID: PMC10401736.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401736/
An interrupted time series analysis of trends in opioid-related emergency department visits from pre-COVID-19 pandemic to pandemic, from the Canadian Hospitals Injury Reporting and Prevention Program.
Yao X, McFaull SR, Champagne AS, Thompson W.
BMC Public Health. 2023 Aug 4;23(1):1483. doi: 10.1186/s12889-023-16414-z. PMID: 37537534; PMCID: PMC10401736.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401736/
The Fentanyl System Shock - Are There Lessons to Learn From the COVID-19 System Shock Framework? Comment on "The COVID-19 System Shock Framework: Capturing Health System Innovation During the COVID-19 Pandemic".
Meyer M, Westenberg JN, Krausz RM.
Int J Health Policy Manag. 2023;12:7409. doi: 10.34172/ijhpm.2023.7409. Epub 2023 Mar 5. PMID: 37579419; PMCID: PMC10461848.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461848/
The Fentanyl System Shock - Are There Lessons to Learn From the COVID-19 System Shock Framework? Comment on "The COVID-19 System Shock Framework: Capturing Health System Innovation During the COVID-19 Pandemic".
Meyer M, Westenberg JN, Krausz RM.
Int J Health Policy Manag. 2023;12:7409. doi: 10.34172/ijhpm.2023.7409. Epub 2023 Mar 5. PMID: 37579419; PMCID: PMC10461848.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10461848/
Trends in Substance Use and Abuse During COVID-19 Among the General Population.
Shankar R, Bhattacharya V.
Addict Health. 2022 Oct;14(4):296-308. doi: 10.34172/ahj.2022.1274. Epub 2022 Oct 29. PMID: 37559794; PMCID: PMC10408753.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408753/
Trends in Substance Use and Abuse During COVID-19 Among the General Population.
Shankar R, Bhattacharya V.
Addict Health. 2022 Oct;14(4):296-308. doi: 10.34172/ahj.2022.1274. Epub 2022 Oct 29. PMID: 37559794; PMCID: PMC10408753.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408753/
Estimating the uncertain effect of the COVID pandemic on drug overdoses.
Moghtaderi A, Zocchi MS, Pines JM, Venkat A, Black B (2023)
PLoS ONE 18(8): e0281227. doi.org/10.1371/journal.pone.0281227
https://www.sciencedirect.com/science/article/pii/S0955395923002049
Estimating the uncertain effect of the COVID pandemic on drug overdoses.
Moghtaderi A, Zocchi MS, Pines JM, Venkat A, Black B (2023)
PLoS ONE 18(8): e0281227. doi.org/10.1371/journal.pone.0281227
https://www.sciencedirect.com/science/article/pii/S0955395923002049
Seite 1 von 3